发明名称 MODIFIED PEPTIDES AS THERAPEUTIC AGENTS
摘要 The present invention concerns fusion of Fc domains with biologically active peptides and a process for preparing pharmaceutical agents using biologicall y active peptides. In this invention, pharmacologically active compounds are prepared by a process comprising: a) selecting at least one peptide that modulates the activity of a protein of interest; and b) preparing a pharmacologic agent comprising an Fc domain covalently linked to at least on e amino acid of the selected peptide. Linkage to the vehicle increases the hal f- life of the peptide, which otherwise would be quickly degraded in vivo. The preferred vehicle is an Fc domain. The peptide can be selected, for example, by phage display, E.coli display, ribosome display, RNA-peptide screening, yeast-based screening, chemical-peptide screening, rational design, or prote in structural analysis.
申请公布号 CA2407956(A1) 申请公布日期 2001.11.08
申请号 CA20012407956 申请日期 2001.05.02
申请人 AMGEN INC. 发明人 BOONE, THOMAS CHARLES;GUDAS, JEAN MARIE;FEIGE, ULRICH;CHEETHAM, JANET C.;LIU, CHUAN-FA
分类号 C12N15/02;A61K47/48;A61P3/02;A61P7/04;A61P7/06;A61P13/02;A61P17/02;A61P31/18;A61P35/04;A61P37/02;A61P43/00;C07K14/505;C07K14/52;C07K14/545;C07K16/18;C07K19/00;C12N1/21;C12P21/08;C12R1/19;(IPC1-7):C07K19/00;C12N15/62;C12N15/70 主分类号 C12N15/02
代理机构 代理人
主权项
地址